These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4253029)

  • 1. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia.
    Davis RB
    Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe serogenic hemolytic anemia caused by anti-D fraction in factor VIII concentrate].
    Schricker KT; Schrenk KH
    Thromb Diath Haemorrh; 1972 Jul; 27(3):523-8. PubMed ID: 4197045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Percutaneous nephrolithotripsy supported by recombinant factor VIII in a patient with hemophilia A, a Jehovah's Witness].
    Azuno Y; Kaku K
    Rinsho Ketsueki; 1995 Dec; 36(12):1337-41. PubMed ID: 8587168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and use of factor VIII concentrates in hemophilia].
    Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL
    Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemostatic treatment with cryoprecipitate and antifibrinolytics in a hemophilic patient subjected to tonsillectomy].
    Mancini AF; Rosito P; Paolucci G; Zanini A
    Minerva Pediatr; 1971 May; 23(19):868-75. PubMed ID: 5560087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Posttraumatic thigh amputation with secondary healing in hemophilia A].
    Hörning I; Gringmuth-Dallmer H; Römer KH
    Zentralbl Chir; 1968 Nov; 93(45):1575-80. PubMed ID: 5705709
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
    Stine KC; Becton DL
    Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractures and dislocations in hemophilia.
    Boardman KP; English P
    Clin Orthop Relat Res; 1980 May; (148):221-32. PubMed ID: 6103772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIII in hemophilia A: the Canadian experience.
    Blanchette VS
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular hemorrhage in a patient with hemophilia.
    Kobayashi H; Honda Y
    Metab Ophthalmol; 1984-1985; 8(1):27-30. PubMed ID: 6441096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative care of the patient with hemophilia undergoing urgent appendectomy.
    Redwine J; Bold RJ
    Arch Surg; 2007 Sep; 142(9):894-7. PubMed ID: 17875845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hemophilia with factor 8 concentrates.
    Dallman PR; Pool JG
    N Engl J Med; 1968 Jan; 278(4):199-202. PubMed ID: 5711341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rules and regulations in the therapy of hemophilia].
    Landbeck G; Kurme A
    Fortschr Med; 1972 May; 90(14):542-6. PubMed ID: 5072274
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hemophilia with glycine-precipitated factor 8.
    Abildgaard CF; Simone JV; Corrigan JJ; Seeler RA; Edelstein G; Vanderheiden J; Schulman I
    N Engl J Med; 1966 Sep; 275(9):471-5. PubMed ID: 5917942
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
    Strauss HS
    R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.
    Auerswald G; Spranger T; Brackmann HH
    Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 20. Supply and need of factor VIII concentrates.
    Britten A; Etzel F; Ala F; Carman C; Smit Sibinga C
    Haematologia (Budap); 1983; 16(1-4):109-20. PubMed ID: 6434377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.